ZYX and breast carcinoma: Zyxin-knockdown in MDA-MB-231 breast cancer cells abrogates the TGFβ-mediated E-cadherin downregulation and impairs TGFβ-induced cell motility, supporting the notion that zyxin controls TGFβ-induced migration [162].